Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Anavex Lf SC (AVXL)

Anavex Lf SC (AVXL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Anavex’s Blarcamesine Achieves Pre-specified Efficacy in Phase IIb/III Alzheimer’s Trial: Data Presented at CTAD Conference 2024 GlobeNewswire - Thu Oct 31, 3:00AM CDT

AVXL : 9.02 (-1.42%)
Anavex Life Sciences Announces Encouraging Preliminary Biomarker Results from Ongoing Phase 2 Study of ANAVEX®3-71 for the Treatment of Schizophrenia GlobeNewswire - Thu Oct 17, 6:30AM CDT

AVXL : 9.02 (-1.42%)
Annovis Bio (NYSE: ANVS) Presented Recent Achievements at H.C. Wainwright Conference Investor Brand Network - Thu Sep 26, 9:15AM CDT

Annovis Bio (NYSE: ANVS), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer’s disease (“AD”) and Parkinson’s disease...

LGVN : 2.30 (+5.99%)
ANVS : 7.54 (-1.44%)
AVXL : 9.02 (-1.42%)
Anavex Life Sciences: Fiscal Q3 Earnings Snapshot AP - Tue Aug 6, 6:48AM CDT

Anavex Life Sciences: Fiscal Q3 Earnings Snapshot

AVXL : 9.02 (-1.42%)
Anavex Life Sciences: Fiscal Q2 Earnings Snapshot AP - Thu May 9, 6:41AM CDT

Anavex Life Sciences: Fiscal Q2 Earnings Snapshot

AVXL : 9.02 (-1.42%)
Anavex Life Sciences: Fiscal Q1 Earnings Snapshot AP - Wed Feb 7, 6:43AM CST

Anavex Life Sciences: Fiscal Q1 Earnings Snapshot

AVXL : 9.02 (-1.42%)
Anavex Life Sciences: Fiscal Q4 Earnings Snapshot AP - Mon Nov 27, 2023

Anavex Life Sciences: Fiscal Q4 Earnings Snapshot

AVXL : 9.02 (-1.42%)
Anavex Life Sciences: Fiscal Q3 Earnings Snapshot AP - Tue Aug 8, 2023

Anavex Life Sciences: Fiscal Q3 Earnings Snapshot

AVXL : 9.02 (-1.42%)
Anavex Life Sciences: Fiscal Q2 Earnings Snapshot AP - Tue May 9, 2023

Anavex Life Sciences: Fiscal Q2 Earnings Snapshot

AVXL : 9.02 (-1.42%)
Wall Street Thinks This Small-Cap Stock Can Quadruple in Value Motley Fool - Wed Mar 15, 2023

The company generates no revenue, but it may be worth taking a chance on as it possesses lots of upside.

JPM : 239.56 (+0.11%)
AVXL : 9.02 (-1.42%)

Barchart Exclusives

1 Dividend Aristocrat to Bet on Trump's Tariffs and the Fed's Rate Cuts Barchart - Tue Nov 12, 6:30PM CST
Nucor is one stock that stands to benefit from the Fed's rate cuts as well as any possible tariffs under a Trump administration. It is also a dividend aristocrat, and has increased its payouts for over 5 decades. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot